𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Successful identification and management of high-risk patients with acute myocardial infarction

✍ Scribed by R. David Anderson; E. Magnus Ohman

Publisher
Springer US
Year
1996
Tongue
English
Weight
860 KB
Volume
3
Category
Article
ISSN
0929-5305

No coin nor oath required. For personal study only.

✦ Synopsis

The decision to use thrombolytic therapy in patients with acute myocardial infarction has been validated in recent large clinical trials. The identification of the high-risk patient, whether or not to use adjunctive strategies, and which patients may benefit from them are less clear. This article provides an overview of risk assessment for the patient with an acute myocardial infarction and the rationale for the use of certain clinical, electrocardiographic, and laboratory features in identifying patients at high risk. Also included is a discussion of the role of coronary angiography in the risk stratification of this patient population. Lastly, we explore the use of mechanical approaches to revascularization and suggest a treatment strategy based on the severity of the patient's coronary disease.

πŸ“œ SIMILAR VOLUMES

Selective drug-eluting stent implantatio
Selective drug-eluting stent implantation for high-risk patients with acute ST-elevation myocardial infarction: Rationale and safety
✍ Sandhir B. Prasad; Thomas David; Yuvaraj Malaiapan; James D. Cameron; Ian T. Mer πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 155 KB πŸ‘ 2 views

## Abstract Background: A selective policy of drug‐eluting stent (DES) implantation in ST‐elevation myocardial infarction (STEMI) patients at high risk of restenosis may maximize the benefit from restenosis reduction and minimize risk from late stent thrombosis (LaST). Objectives: We sought to pros

Safety of gadoversetamide in patients wi
Safety of gadoversetamide in patients with acute and chronic myocardial infarction
✍ S. Huber; R. Muthupillai; B. Cheong; J.H. Wible Jr; D. Shah; P. Woodard; F. Grot πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 122 KB

## Abstract ## Purpose To assess the safety data from two large, multicenter, phase 2 trials on the use of gadoversetamide (OptiMARK, Tyco Healthcare/Mallinckrodt, St. Louis, MO) as a contrast agent in delayed hyperenhancement magnetic resonance imaging (DE‐MRI) in patients with acute and chronic